Früh E, Elgert C, Eggert F, Scherneck S, Rustenbeck I: Glucagonotropic and glucagonostatic effects of KATP channel closure and potassium depolarization. Endocrinology (doi: 10.1210/endocr/bqaa136), 2020
Grupe K, Asuaje Pfeifer M, Dannehl F, Liebmann M, Rustenbeck I, Schürmann A, Scherneck S: Metabolic changes during pregnancy in glucose-intolerant NZO mice: A polygenic model with prediabetic metabolism. Physiol Rep 8: e14417, 2020
Kluth O, Stadion M, Gottmann P, Aga H, Jähnert M, Scherneck S, Vogel H, Krus U, Seelig A, Ling C, Gerdes J, Schürmann A: Decreased Expression of Cilia Genes in Pancreatic Islets as a Risk Factor for Type 2 Diabetes in Mice and Humans. Cell Rep 26: 3027-3036, 2019
Schmidt JJ, Strunk AK, David S, Bode-Böger SM, Martens-Lobenhoffer J, Knitsch W, Scherneck S, Welte T, Kielstein JT: Single- and multiple-dose pharmacokinetics and total removal of colistin in critically ill patients with acute kidney injury undergoing prolonged intermittent renal replacement therapy. J Antimicrob Chemother 74: 997-1002, 2019
Scherneck S, Schlinke N, Beck E, Grupe K, Weber-Schoendorfer C, Schaefer C: Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort study. Reprod Toxicol 81: 79-83, 2018
Felberg M, Reckers K, Schulz M, Scherneck S: Community pharmacist care of patients with diabetes: Opportunities and limitations. Med Monatsschr Pharm 40: 496-501, 2017
Scholz G, Xu Q, Schulze T, Boht H, Mattern K, Hartmann J, Dietzel A, Scherneck S, Rustenbeck I, Prades JD, Fündling S, Wasisto HS, Waag A: LED-Based Tomographic Imaging for Live-Cell Monitoring of Pancreatic Islets in Microfluidic Channels. Proceedings 1: 552, 2017
Vogel H, Jähnert M, Stadion M, Matzke D, Scherneck S, Schürmann A: A vast genomic deletion in the C56BL/6 genome affects different genes within the Ifi200 cluster on chromosome 1 and mediates obesity and insulin resistance. BMC Genomics 18: 172, 2017
Chung B, Stadion M, Schulz N, Jain D, Scherneck S, Joost HG, Schürmann A: The diabetes gene Zfp69 modulates hepatic insulin sensitivity in mice. Diabetologia: 2403-13, 2015
Kluth O, Matzke D, Kamitz A, Jähnert M, Vogel H, Scherneck S, Schulze M, Staiger H, Machicao F, Häring HU, Joost HG, Schürmann A: Identification of Four Mouse Diabetes Candidate Genes Altering β-Cell Proliferation. PLoS Genetics 11: e1005506, 2015
Scherneck S, Schöpa FL, Entezami M, Kayser A, Weber-Schoendorfer C, Schaefer C: Reversible oligohydramnios in the second trimester of pregnancy in two patients with long-term diclofenac exposure. Reprod Toxicol 58: 61-64, 2015
Vogel H, Montag D, Kanzleiter T, Jonas W, Matzke D, Scherneck S, Chadt A, Töle J, Kluge R, Joost HG, Schürmann A: An interval of the obesity QTL Nob3.38 within a QTL hotspot on chromosome 1 modulates behavioral phenotypes. PLoS One 8: e53025, 2013
Gorboulev V, Schürmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, Veyhl-Wichmann M, Srinivasan A, Balen D, Breljak D, Rexhepaj R, Parker HE, Gribble FM, Reimann F, Lang F, Wiese S, Sabolic I, Sendtner M, Koepsell H: Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61: 187-96, 2012
Lubura M, Hesse D, Neumann N, Scherneck S, Wiedmer P, Schürmann A: Non-invasive quantification of white and brown adipose tissues and liver fat content by computed tomography in mice. PLoS One 7: e37026, 2012
Vogel H, Scherneck S, Kanzleiter T, Benz V, Kluge R, Stadion M, Kryvych S, Blüher M, Klöting N, Joost HG, Schürmann A: Loss of function of Ifi202b by a microdeletion on chromosome 1 of C57BL/6J mice suppresses 11β-hydroxysteroid dehydrogenase type 1 expression and development of obesity. Hum Mol Genet 21: 3845-57, 2012
Kluth O, Mirhashemi F, Scherneck S, Kaiser D, Kluge R, Neschen S, Joost HG, Schürmann A: Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure. Diabetologia 54: 605-616, 2011
Mirhashemi F, Scherneck S, Kluth O, Kaiser D, Vogel H, Kluge R, Schürmann A, Neschen S, Joost HG: Diet dependence of diabetes in the New Zealand Obese (NZO) mouse: Total fat, but not fat quality or sucrose accelerates and aggravates diabetes. Exp Clin Endocrinol Diabetes 119: 167-171, 2011
Schulz N, Himmelbauer H, Rath M, van Weeghel M, Houten S, Kulik W, Suhre K, Scherneck S, Vogel H, Kluge R, Wiedmer P, Joost HG, Schürmann A: Role of medium- and short-chain L-3-hydroxyacyl-CoA dehydrogenase in the regulation of body weight and thermogenesis. Endocrinology 152: 4641-51, 2011
Balwierz A, Polus A, Razny U, Wator L, Dyduch G, Tomaszewska R, Scherneck S, Joost H, Dembinska-Kiec A: Angiogenesis in the New Zealand obese mouse model fed with high fat diet. Lipids in Health and Disease 6, 8-13, 2009
Scherneck S, Nestler M, Vogel H, Blüher M, Block MD, Diaz MB, Herzig S, Schulz N, Teichert M, Tischer S, Al-Hasani H, Kluge R, Schürmann A, Joost HG: Positional Cloning of Zinc Finger Domain Transcription Factor Zfp69, a Candidate Gene for Obesity-Associated Diabetes Contributed by Mouse Locus Nidd/SJL. PLoS Genetics 5: e1000541, 2009
Vogel H, Nestler M, Rüschendorf F, Block MD, Tischer S, Kluge R, Schürmann A, Joost HG, Scherneck S: Characterisation of Nob3, a major quantitative trait locus for obesity and hyperglycaemia on mouse Chromosome 1. Physiol Genomics 38:226-232, 2009
Chadt A, Leicht K, Deshmukh A, Jiang LQ, Scherneck S, Bernhardt U, Dreja T, Vogel H, Schmolz K, Kluge R, Zierath JR, Hultschig C, Hoeben RC, Schürmann A, Joost HG, Al-Hasani H: Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nature Genetics 40:1354-1359, 2008
Mirhashemi F, Kluth O, Scherneck S, Vogel H, Kluge R, Schürmann A, Joost HG, Neschen S: High-fat, carbohydrate-free diet markedly aggravates obesity but prevents beta cell loss and diabetes in the obese, diabetes-susceptible db/db strain. Obesity Facts 1:292-297, 2008
Neschen S, Katterle Y, Richter J, Augustin R, Scherneck S, Mirhashemi F, Schürmann A, Joost HG, Klaus S: Uncoupling protein 1 expression in murine skeletal muscle increases AMPK activation, glucose turnover, and insulin sensitivity in vivo. Physiol Genomics 33:333-340, 2008
Schmidt S, Richter M, Montag D, Sartorius T, Gawlik V, Hennige AM, Scherneck S, Himmelbauer H, Lutz SZ, Augustin R, Kluge R, Ruth P, Joost HG, Schürmann A: Neuronal functions, feeding behavior and energy balance in Slc2a3+/- mice. Am J Physiol Endocrinol Metab 295:1084-1094, 2008
Jürgens HS, Neschen S, Ortmann S, Scherneck S, Schmolz K, Schüler G, Schmidt S, Blüher M, Klaus S, Perez-Tilve D, Tschöp MH, Schürmann A, Joost HG: Development of diabetes in obese, insulin-resistant mice: essential role of dietary carbohydrate in beta cell destruction. Diabetologia 50:1481-1489, 2007
Schmolz K, Pyrski M, Bufe B, Vogel H, Nogueiras R, Scherneck S, Nestler M, Zahn C, Rüschendorf F, Tschöp MH, Meyerhof W, Joost HG, Schürmann A: Role of neuromedin-U in the central control of feeding behaviour: a variant of the neuromedin-U receptor 2 contributes to hyperphagia in the New Zealand obese mouse. Obesity and Metabolism 3:28-37, 2007
Dirk I, Hüttel E, Scherneck S: Communication of drug risks in pregnancy. PHARMAKON 8: 398-403, 2020
Kielstein JT, Kruse AK, Anderson N, Vaitiekunas H, Scherneck S: Hot rods in the ICU: What is the antibiotic mileage of your renal replacement therapy? Med Klin Intensivmed Notfmed: 114: 139-145, 2019
Pohl M, Scherneck S: Adherence in the therapy of type 2 diabetes. Med Monatsschr Pharm 42: 338-342, 2019
Scherneck S, Schaefer C: Schwangerschaft und Diabetes: Insulin ist Trumpf [Zweitdruck als bearbeitete Übernahme aus: Der Allgemeinarzt 37]. Ars Medici 106: 276-278, 2016
Scherneck S, Schaefer C: Schwangerschaft und Diabetes: Insulin ist Trumpf. Der Allgemeinarzt 37: 25-28, 2015
Scherneck S, Vogel H, Nestler M, Kluge R, Schürmann A, Joost HG: Role of zinc finger transcription factor Zfp69 in body fat storage and diabetes susceptibility of mice. Results Probl Cell Differ. 52: 57-68, 2010
Scherneck S, Schaefer C: Schwangerschaft und Stillzeit. In: Jaehde U, Radziwill R, Kloft C (eds.) Klinische Pharmazie: Grundlagen und Anwendung (379-388), Wissenschaftliche Verlagsgesellschaft Stuttgart mbH, Stuttgart, 2017
Chadt A, Scherneck S, Joost HG, Al-Hasani H: Molecular links between Obesity and Diabetes: "Diabesity". In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO (eds.) Endotext, MDText.com, South Dartmouth (MA), 2014 (Last Update: January 23, 2018)
Kluge R, Scherneck S, Schürmann S, Joost HG: Pathophysiology and Genetics of Obesity and Diabetes in the New Zealand Obese Mouse: A Model of the Human Metabolic Syndrome. In: Joost HG, Al-Hasani H, Schürmann S (eds.) Animal Models in Diabetes Research (Methods in Molecular Biology 933: 59-73), Humana Press, New York, 2012
Hofmann S, Krahmer F, Scherneck S: Die Zukunft der Juniorprofessur: Chancen und Herausforderungen auf dem Weg zur frühen Selbstständigkeit. Physik Journal 18: 3, 2019
Krahmer F, Scherneck S, Hofmann S: Selbstständigkeit und Führungsverantwortung: Ein Plädoyer für die Juniorprofessur. Forschung & Lehre 26: 436-438, 2019
Siebenpfeiffer H, Thomalla E, Krahmer F, Scherneck S, Hofmann S, Potthoff T, Vogel F, Kappeler F: 2. Juniorprofessur bzw. Tenure-Track-Programm, Mitteilungen des Deutschen Germanistenverbandes 65 (2), 139-153, 2018
Scherneck S: Kongress aktuell, Typ-2-Diabetes: Degeneration and regeneration of the islets. Diabeteszeitung 2 (4): 14, 2017
Pöppelbuß J, Krahmer F, Scherneck S, Potthoff T: Transparente Karriereplanung - Was entwickelt sich aus der Juniorprofessur? BIOspektrum 23: 243, 2017
Pöppelbuß J, Scherneck S, Krahmer F: Ein Schritt in die richtige Richtung: Der Tenure Track aus Sicht der Juniorprofessorinnen und Juniorprofessoren. Forschung & Lehre 24: 110-111, 2017
Pöppelbuß J, Scherneck S, Krahmer F: Rezension zu: Hochschulsoziologie: Burkhardt A, Nickel S (eds.): Die Juniorprofessur. Neue und alte Qualifikationswege im Vergleich. Köln Z Soziol 68: 583-586, 2016